Empirical Antifungal Treatment in ICUS

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Invasive Candidiasis
Interventions
DRUG

Micafungin

"MYCAMINE 100 mg intravenous 100 mg of powder reconstituted in a 100 ml infusion bag of sodium chloride 0.9%~infusion over 24 hours for 14 days discontinuation of treatment if proven invasive candidiasis"

DRUG

PLACEBO

solution of sodium chloride 0.9% 100 ml for intravenous infusion infusion over 24 hours for 14 days discontinuation of placebo if proven invasive candidiasis

Trial Locations (22)

13616

Hospital Aix en Provence, Aix-en-Provence

21000

University Hospital of Dijon, Dijon

33000

Hospital University of Bordeaux, Bordeaux

34295

Hospital University of Montpellier, Montpellier

38043

Hospital University of Grenoble, Grenoble

42055

University Hospital of Saint Etienne, Saint-Etienne

51092

Hospital University of Reims, Reims

63003

Hospital University of Clermont Ferrand, Clermont-Ferrand

67091

Hospital University of Besançon, Besançon

University Hospital of Strasbourg, Strasbourg

75010

University Hospital Saint Louis, Paris

75013

University Hospital of La Pitié Salpetrière, Paris

75014

Hospital St Joseph, Paris

75877

Hospital University of Bichat, Paris

78150

Hospital of Versailles, Le Chesnay

83300

Hospital of Draguignan, Draguignan

85925

Departemental Hospital of Roche sur Yon, La Roche-sur-Yon

92110

University Hospital of Beaujon, Clichy

93009

University Hospital of Avicennes, Bobigny

93105

Interegional Hospital André Grégoire, Montreuil

95303

Hospital of Pontoise, Pontoise

96433

University Hospital Edouard Herriot, Lyon

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT01773876 - Empirical Antifungal Treatment in ICUS | Biotech Hunter | Biotech Hunter